Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities | ||
By: GlobeNewswire - 25 May 2022 | Back to overview list |
|
Company announcement – No. 24 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, May 25, 2022 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces that it has received information on transactions in Zealand shares or related securities by persons discharging managerial responsibilities. Please see the attached files. # # # About Zealand Pharma A/S Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in Boston, and Marlborough (MA). For more information about Zealand’s business and activities, please visit http://www.zealandpharma.com. Forward-Looking Statement For further information, please contact: Zealand Pharma Investor Relations Zealand Pharma Media Relations Attachments
|
||
|
||
Copyright 2022 GlobeNewswire | Back to overview list |